Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Elias Dakwar, Amy Mahony, C. Jean Choi, Martina Pavlicova, Daniel Brooks, John J. Mariani & Frances R. Levin. (2020) Guanfacine extended-release for cannabis use disorder: a pilot feasibility trial. The American Journal of Drug and Alcohol Abuse 46:1, pages 44-48.
Read now
Read now
Nicholas T Bello. (2015) Clinical utility of guanfacine extended release in the treatment of ADHD in children and adolescents. Patient Preference and Adherence 9, pages 877-885.
Read now
Read now
Sophie Duong, Kara Chung & Sharon B Wigal. (2012) Metabolic, toxicological, and safety considerations for drugs used to treat ADHD. Expert Opinion on Drug Metabolism & Toxicology 8:5, pages 543-552.
Read now
Read now
Xue Ming, Martha Mulvey, Sharanya Mohanty & Viraj Patel. (2011) Safety and efficacy of clonidine and clonidine extended-release in the treatment of children and adolescents with attention deficit and hyperactivity disorders. Adolescent Health, Medicine and Therapeutics 2, pages 105-112.
Read now
Read now
Articles from other publishers (24)
Hueng-Chuen Fan, Kuo-Liang Chiang, Kuang-Hsi Chang, Chuan-Mu Chen & Jeng-Dau Tsai. (2023) Epilepsy and Attention Deficit Hyperactivity Disorder: Connection, Chance, and Challenges. International Journal of Molecular Sciences 24:6, pages 5270.
Crossref
Crossref
Matthew J. Gurka, Siraj U. Siddiqi, Stephanie L. Filipp, Rebeccah Mercado, Lindsay A. Thompson, David M. Janicke & Elizabeth A. Shenkman. (2020)
Attention deficit hyperactivity disorder medications and
BMI
trajectories: The role of medication type, sex and age
. Pediatric Obesity 16:4.
Crossref
Crossref
Marco Emili, Fiorenza Stagni, Maria Elisa Salvalai, Beatrice Uguagliati, Andrea Giacomini, Christelle Albac, Marie-Claude Potier, Mariagrazia Grilli, Renata Bartesaghi & Sandra Guidi. (2020) Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome. Neurobiology of Disease 140, pages 104874.
Crossref
Crossref
Kosuke Okazaki, Kazuhiko Yamamuro, Junzo Iida & Toshifumi Kishimoto. (2019) Guanfacine monotherapy for ADHD/ASD comorbid with Tourette syndrome: a case report. Annals of General Psychiatry 18:1.
Crossref
Crossref
Daryl Efron. 2019. Sleep and ADHD. Sleep and ADHD
1
28
.
Amber D. Hunt, David W. Dunn, Hillary S. Blake & Jennifer Downs. 2019. Treatment Resistance in Psychiatry. Treatment Resistance in Psychiatry
215
235
.
Mark J Millan, Jean-Michel Rivet & Alain Gobert. (2016) The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders. Journal of Psychopharmacology 30:11, pages 1099-1128.
Crossref
Crossref
Leslie Briars & Timothy Todd. (2016) A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. The Journal of Pediatric Pharmacology and Therapeutics 21:3, pages 192-206.
Crossref
Crossref
Bart Ellenbroek & Jiun Youn. 2016. Gene-Environment Interactions in Psychiatry. Gene-Environment Interactions in Psychiatry
233
288
.
Michael Huss, Wai Chen & Andrea G. Ludolph. (2015) Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe. Clinical Drug Investigation 36:1, pages 1-25.
Crossref
Crossref
Aleksandra Wasilewska, Franciszek Sączewski, Alan L. Hudson, Mehnaz Ferdousi, Mika Scheinin, Jonne M. Laurila, Apolonia Rybczyńska, Konrad Boblewski & Artur Lehmann. (2014) Fluorinated analogues of marsanidine, a highly α2-AR/imidazoline I1 binding site-selective hypotensive agent. Synthesis and biological activities. European Journal of Medicinal Chemistry 87, pages 386-397.
Crossref
Crossref
Simona Ruggiero, Antonio Clavenna, Laura Reale, Annalisa Capuano, Francesco Rossi & Maurizio Bonati. (2014) Guanfacine for attention deficit and hyperactivity disorder in pediatrics: A systematic review and meta-analysis. European Neuropsychopharmacology 24:10, pages 1578-1590.
Crossref
Crossref
Floyd SalleeDaniel F. ConnorJeffrey H. Newcorn. (2013)
A Review of the Rationale and Clinical Utilization of α
2
-Adrenoceptor Agonists for the Treatment of Attention-Deficit/Hyperactivity and Related Disorders
. Journal of Child and Adolescent Psychopharmacology 23:5, pages 308-319.
Crossref
Crossref
Michael H. Bloch, Daniel A. Gorman & Elia Abi-Jaoude. (2012) Commentaries on ‘Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders’. Evidence-Based Child Health: A Cochrane Review Journal 7:4, pages 1231-1234.
Crossref
Crossref
Ann C. Childress. (2012) Guanfacine Extended Release as Adjunctive Therapy to Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. Advances in Therapy 29:5, pages 385-400.
Crossref
Crossref
Jamie D. Croxtall. (2012) Clonidine Extended-Release In Attention-Deficit Hyperactivity Disorder†. CNS Drugs 26:3, pages 277-279.
Crossref
Crossref
Mark J. Millan, Yves Agid, Martin Brüne, Edward T. Bullmore, Cameron S. Carter, Nicola S. Clayton, Richard Connor, Sabrina Davis, Bill Deakin, Robert J. DeRubeis, Bruno Dubois, Mark A. Geyer, Guy M. Goodwin, Philip Gorwood, Thérèse M. Jay, Marian Joëls, Isabelle M. Mansuy, Andreas Meyer-Lindenberg, Declan Murphy, Edmund Rolls, Bernd Saletu, Michael Spedding, John Sweeney, Miles Whittington & Larry J. Young. (2012) Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nature Reviews Drug Discovery 11:2, pages 141-168.
Crossref
Crossref
Timothy E. Wilens, Oscar Bukstein, Matthew Brams, Andrew J. Cutler, Ann Childress, Thomas Rugino, Andrew Lyne, Kara Grannis & Sharon Youcha. (2012) A Controlled Trial of Extended-Release Guanfacine and Psychostimulants for Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry 51:1, pages 74-85.e2.
Crossref
Crossref
Michael G. Kölch, Paul L. Plener & Jörg M. Fegert. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie
1185
1198
.
Hans‐Willi Clement & Eberhard Schulz. (2011)
α
2
‐Agonisten und adrenerge Pharmaka bei ADHS
. Pharmazie in unserer Zeit 40:6, pages 503-509.
Crossref
Crossref
Jamie D. Croxtall. (2011) Clonidine Extended-Release. Pediatric Drugs 13:5, pages 329-336.
Crossref
Crossref
Edward D. Levin, Philip J. Bushnell & Amir H. Rezvani. (2011) Attention-modulating effects of cognitive enhancers. Pharmacology Biochemistry and Behavior 99:2, pages 146-154.
Crossref
Crossref
Philip Hazell. (2011) The challenges to demonstrating long-term effects of psychostimulant treatment for attention-deficit/hyperactivity disorder. Current Opinion in Psychiatry 24:4, pages 286-290.
Crossref
Crossref
Jonathan S. Dowben, Joan S Grant & Norman L Keltner. (2011) Clonidine: Diverse Use in Pharmacologic Management. Perspectives in Psychiatric Care 47:2, pages 105-108.
Crossref
Crossref